Last update:

Oncology & Cancer news

Oncology & Cancer

Study shows mechanical stiffness of tissue can alter fate of tumor cell populations

Ongoing fundamental research on cancer cells could be used to create new drugs and therapies that fight the spread of cancer cells. The work of Dr. Tanmay Lele, joint faculty in chemical engineering, and chemical engineering ...

Oncology & Cancer

All in the blood: New way to detect drug resistance in ovarian cancer patients

Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients who are likely to become resistant to PARP inhibitors (PARPi), a key therapy used to treat ovarian ...

Oncology & Cancer

Detecting pancreatic cancer

November is National Pancreatic Cancer Awareness Month. Approximately 66,000 people in the U.S. will be diagnosed with pancreatic cancer this year, according to the National Cancer Institute.

Oncology & Cancer

'Moonlighting' enzymes may lead to new cancer therapies

Researchers at the Center for Genomic Regulation (CRG) reveal that metabolic enzymes known for their roles in energy production and nucleotide synthesis are taking on unexpected "second jobs" within the nucleus, orchestrating ...

Oncology & Cancer

Medicaid enrollment continuity tied to lymphoma stage at diagnosis

Continuous enrollment in Medicaid was associated with a lower rate of a late-stage lymphoma diagnosis in children and adolescents/young adults (AYAs). However, fewer than half of Medicaid-insured patients in these age ranges ...

Oncology & Cancer

Pembrolizumab aids survival with high-risk endometrial cancer

Pembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published online Oct. 16 in the Journal of Clinical ...

Oncology & Cancer

In vitro model helps show why breast cancer spreads to bone

Researchers from Tampere University, Finland, and Izmir Institute of Technology, Turkey, have developed an in vitro cancer model to investigate why breast cancer spreads to bone. Their findings hold promise for advancing ...

Oncology & Cancer

3D tattooing after breast reconstruction: Q&A

Breast cancer is the most diagnosed cancer in U.S. women with about one in eight women diagnosed over the course of their lifetime. In about 35% of cases, a mastectomy is part of a woman's treatment plan and involves removing ...

Oncology & Cancer

AI model that checks for skin cancer shows promise

Scientists in the East of England have developed a way of using artificial intelligence to check for skin cancer, with the AI tool outperforming existing methods in a new study.

Oncology & Cancer

Biomarker may predict immunotherapy response in liver cancer

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell Medicine investigators.

Medications

Repurposing drugs to eliminate cellular origins of brain tumors

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation, and chemotherapy. It has become clear in recent years that not all cells ...

Oncology & Cancer

Scientists explore new mechanisms to combat glioblastoma

Glioblastoma is the most common and aggressive type of primary brain tumor, with an average survival rate of 15 months, according to the Centers for Disease Control and Prevention. While glioblastoma can be diagnosed at any ...

Oncology & Cancer

Team identifies origin of deadly ovarian cancer

Researchers have identified the origin of ovarian cancer that develops in the fallopian tube, which opens doors to discovering new methods for diagnosing the disease and potential therapies.